CARE Ratings Q2 FY27: Revenue Jumps 20% YoY to ₹164.13 Crore; PAT Up 26%
CARE Ratings reported a 20% YoY increase in consolidated operating income to ₹164.13 crore for Q2 FY27. PAT grew 26% YoY to ₹72.37 crore. For H1 FY27, consolidated operating income rose 20% YoY to ₹275.81 crore, with PAT up 26% YoY to ₹105.36 crore. The company declared an interim dividend of ₹10 per share.
The financial results show significant growth, which is positive for investors. The declaration of an interim dividend is also a positive signal. However, the impact is considered medium as it reflects routine quarterly performance and dividend payout.
The company reported strong year-on-year growth in both revenue and profit for the quarter and half-year ended September 30, 2026, along with the declaration of an interim dividend, indicating positive financial performance.
CARE Ratings Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2026. For the second quarter of FY27, the company reported a consolidated operating income of ₹164.13 crore, a 20% year-on-year increase. EBITDA stood at ₹84.61 crore, up 23% YoY, with a margin of 52%. Profit After Tax (PAT) was ₹72.37 crore, a 26% YoY increase, maintaining a margin of 40%. On a standalone basis, operating income was ₹134.21 crore, a 17% YoY increase, while EBITDA was ₹77.99 crore, up 20% YoY with a 58% margin. Standalone PAT was ₹69.16 crore, up 24% YoY, with a 46% margin.
For the half-year ended September 30, 2026, consolidated operating income grew by 20% YoY to ₹275.81 crore. EBITDA was ₹119.25 crore, up 24% YoY with a 43% margin. PAT stood at ₹105.36 crore, a 26% YoY increase, with a 34% margin. Standalone operating income increased by 17% YoY to ₹222.36 crore. EBITDA was ₹110.09 crore, up 19% YoY with a 50% margin. Standalone PAT was ₹103.04 crore, up 21% YoY, with a 41% margin.
The company's Managing Director & Group CEO, Mehul Pandya, commented on the results, highlighting the resilience of the Indian economy and CARE Ratings' sustained momentum. Both ratings and non-ratings businesses reported robust growth. The Board of Directors also declared an interim dividend of ₹10 per share for the second quarter of FY27.
What to do with a filing like this
CARE Ratings Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by CARE Ratings Limited. Read the original for the full detail.